Gut Microbiota Composition and Fecal Metabolic Phenotype in Patients With Acute Anterior UveitisOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined the gut microbiome and the fecal metabolite profile in people with acute anterior uveitis, an inflammatory eye disease. The aim was to see whether gut bacteria or their metabolic products differ from healthy people. Fecal DNA was profiled by high-throughput 16S rDNA sequencing. Fecal metabolites were measured by gas chromatography mass spectrometry (GC-MS), a metabolomics approach, and compared between patients and controls.
Who was studied?
The study analyzed 78 fecal samples for microbiome work: 38 acute anterior uveitis patients and 40 comparison subjects who were family members of patients or sex- and age-matched healthy controls. A separate set of 60 fecal samples went to metabolomics: 30 patients and 30 healthy controls. Participants were adults recruited through an ophthalmology center in Chongqing, China. Both sexes were included across a broad adult age range.
What were the most important findings?
Beta diversity differed significantly between patients and controls. Eight genera including Roseburia were reduced and Veillonella was increased in patients, but these differences lost significance after false discovery rate correction. The fecal metabolite profile was clearly altered. Seven metabolites were raised in patients, including linoleic acid, shikimic acid, azelaic acid, palmitoleic acid, and 6-deoxy-D-glucose. Linoleic acid correlated significantly with Roseburia and Veillonella.
What are the greatest implications of this study?
The strongest signal in acute anterior uveitis was metabolic, not compositional. Gut bacterial abundances did not clearly separate patients from controls once corrected, but the fecal metabolome did. This suggests that what the gut community produces may matter more than which taxa are present when linking the gut to eye inflammation. The cross-sectional design cannot show cause and effect, and larger cohorts are needed to confirm the metabolite differences and their link to specific bacteria.